摘要:
The present invention is to provide an agent for low HDL-cholesterolemia, a prophylactic and/or therapeutic antiarteriosclerosis agent as well as a method for preventing and treating low HDL-cholesterolemia, arteriosclerosis and their related diseases or disorders, with emphasis given to improvement in HDL, without resorting to genetic engineering technology. Further, the present invention is to provide a clinically effective agent for low HDL-cholesterolemia and a prophylactic and/or therapeutic antiarteriosclerosis agent, comprising at least one cysteine protease inhibitor as an active ingredient, thereby increasing a quantity of expressed ABCA1 and elevating blood HDL levels, without using the genetic engineering technology.
摘要:
(24S)- and (24R)-1.alpha.,25-Dihydroxyvitamin D.sub.4 compounds and processes for preparing same. Ergosta-5,7-diene compounds which are useful intermediates in the synthesis of the 1.alpha.,25-dihydroxyvitamin D.sub.4 compounds. The D.sub.4 compounds are expected to possess an interesting pharmacological activity in association with the active-type vitamins D.sub.3 and D.sub.2.
摘要:
An audio frame timing correction method and a wireless device are provided. A controller generates a reference clock for audio coding/decoding such that the reference clock runs fast and moved forward within an audio data sampling interval with the remaining time becoming a margin of the interval. An audio codec decodes demodulated data based on the reference clock, and codes an audio signal based on the reference clock. A demodulator detects wireless frame deviation and determines an adjustment timing whereat the wireless frame symbol timing and the audio frame timing are corrected based on the deviation and the margin. Upon the adjustment timing, the controller synchronizes audio sampling timing with the wireless frame symbol timing.
摘要:
A fuel injection control apparatus for controlling a fuel injection valve including an arithmetic processing section that determines whether a necessary fuel amount is injectable or not within a fuel injectable range from a first fuel injection start timing, computes a second fuel injection start timing in which the necessary fuel amount is injectable within the fuel injectable range in the case that it is not injectable, and controls the fuel injection valve at the computed second fuel injection start timing so as to start fuel injection.
摘要:
This invention relates to a FOUP opener in which a FOUP is placed and the FOUP door of the FOUP can be detached so as to allow access to the interior of the FOUP. The FOUP opener includes a port door having an attaching/detaching mechanism for attaching and detaching the FOUP door and a holding mechanism for holding the FOUP door to be detached, and a port door moving unit for moving said port door holding the FOUP door so as that the FOUP is opened. The port door has a main structure in which said attaching/detaching mechanism is arranged and a surface panel to cover said main structure. The surface panel is detachable from said main structure at a front side of the FOUP opener.
摘要:
To provide a pharmaceutically effective prophylactic/preventive agent for low-HDL cholesterolemia, focusing on an HDL-generating mechanism. The ABCA1 stabilizer of the present invention contains a bisphenol-type compound selected form probucol spiroquinone, probucol diphenoquinone, and probucol bisphenol as an effective ingredient. The ABCA1 stabilizer can continuously and stably express ABCA1 by a mechanism quite different from that of conventional processes, and thus is useful as prophylactic/preventive agent for low-HDL cholesterolemia or arteriosclerosis.
摘要:
The present invention is to provide an agent for low HDL-cholesterolemia, a prophylactic and/or therapeutic antiarteriosclerosis agent as well as a method for preventing and treating low HDL-cholesterolemia, arteriosclerosis and their related diseases or disorders, with emphasis given to improvement in HDL, without resorting to genetic engineering technology. Further, the present invention is to provide a clinically effective agent for low HDL-cholesterolemia and a prophylactic and/or therapeutic antiarteriosclerosis agent, comprising at least one cysteine protease inhibitor as an active ingredient, thereby increasing a quantity of expressed ABCA1 and elevating blood HDL levels, without using the genetic engineering technology.
摘要:
This invention relates to a FOUP opener in which a FOUP is placed and the FOUP door of the FOUP can be detached so as to allow access to the interior of the FOUP. The FOUP opener includes a port door having an attaching/detaching mechanism for attaching and detaching the FOUP door and a holding mechanism for holding the FOUP door to be detached, and a port door moving unit for moving said port door holding the FOUP door so as that the FOUP is opened. The port door has a main structure in which said attaching/detaching mechanism is arranged and a surface panel to cover said main structure. The surface panel is detachable from said main structure at a front side of the FOUP opener.
摘要:
The present invention is to provide an agent for low HDL-cholesterolemia, a prophylactic and/or therapeutic antiarteriosclerosis agent as well as a method for preventing and treating low HDL-cholesterolemia, arteriosclerosis and their related diseases or disorders, with emphasis given to improvement in HDL, without resorting to genetic engineering technology. Further, the present invention is to provide a clinically effective agent for low HDL-cholesterolemia and a prophylactic and/or therapeutic antiarteriosclerosis agent, comprising at least one cysteine protease inhibitor as an active ingredient, thereby increasing a quantity of expressed ABCA1 and elevating blood HDL levels, without using the genetic engineering technology.
摘要:
A shock absorber and suspension strut unit having an outer cylinder containing a predetermined amount of a damping liquid. An inner cylinder is mounted rigidly and concentrically in the outer cylinder and is arranged so as to form an intermediate concentric space between the cylinders. A movable piston rod assembly is movable relative to the double-cylinder assembly and has a piston slidably arranged within the inner cylinder for movement therealong. Check valves are provided in the piston for permitting selective fluid flow from one side of the piston to the other. Further, one or more communication passages are provided in an end of the inner cylinder which abuts the enclosed and the outer cylinder for allowing fluid passage therethrough mutually between a liquid chamber formed below the piston within the inner cylinder and lower part of the annular space formed by and between the cylinders. Thus, these spaces are a substantially unified liquid chamber. A first gas-filled chamber formed at the upper part of the further liquid chamber above the piston within the inner cylinder, while a second gas-filled chamber is formed at the upper part of the annular space. The resulting unit is characterized by the first and second gas-filled chambers being so arranged that either one of them is caused to expand during the contracting or expanding stroke of the unit, while the remaining one of the chambers is caused to simultaneously contract. A fluid flow-limiting passage is provided through the wall of the inner cylinder for allowing free fluid flow passage between the two gas-filled chambers.